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Abstract
Differentiation of naive CD4+ T-cells into functionally distinct T helper (Th) subsets is critical to immunity against
pathogen infection. Little is known about the role of signals emanating from the nuclear envelope for T-cell
differentiation. The nuclear envelope protein lamin A/C is induced in naive CD4+ T-cells upon antigen recognition and
acts as a link between the nucleus and the plasma membrane during T-cell activation. Here we demonstrate that the
absence of lamin A/C in naive T-cell reduces Th1 differentiation without affecting Th2 differentiation in vitro and
in vivo. Moreover, Rag1−/− mice reconstituted with Lmna−/−CD4+CD25− T-cells and infected with vaccinia virus show
weaker Th1 responses and viral removal than mice reconstituted with wild-type T-cells. Th1 responses and pathogen
clearance upon Leishmania major infection were similarly diminished in mice lacking lamin A/C in the complete
immune system or selectively in T-cells. Lamin A/C mediates Th1 polarization by a mechanism involving T-bet and
IFNγ production. Our results reveal a novel role for lamin A/C as key regulator of Th1 differentiation in response to viral
and intracellular parasite infections.
Introduction
The nuclear envelope is composed of nuclear pore
complexes, the outer and inner nuclear membranes, and
the nuclear lamina. The nuclear lamina is a ﬁlamentous
protein layer mainly composed of A- and B-type lamins
and provide mechanical stability to the inner nuclear
membrane, regulating nucleus positioning, chromatin
structure, nuclear pore complex organization, nuclear
envelope breakdown and reassembly during mitosis, DNA
replication, DNA damage responses, cell-cycle progres-
sion, cell differentiation, cell polarization during cell
migration, and transcription1,2. We have previously
shown that lamin A expression is triggered in naive T-
cells upon antigen recognition and enhances T-cell acti-
vation by coupling actin dynamics and immunological
synapse formation3.
T-cells orchestrate the protection against microbial
pathogens4. In peripheral lymphoid organs, antigen-
presenting cells (APCs) stimulate cognate CD4+ T-cells,
which proliferate and undergo differentiation into distinct
specialized effector T helper (Th) cells that are essential
for the development of adaptive immune responses5.
Tight control of naive T-cell differentiation is crucial for
eliciting an appropriate host defense, triggering immune-
mediated inﬂammation without deleterious tissue
damage. Th subsets are deﬁned by the differential
expression of surface markers, transcription factors, and
effector cytokines and play essential and distinct roles in
mediating or directing the nature of the response to
pathogens, commensals, and vaccines. T-cell differentia-
tion in diverse Th subsets depends on the type of antigen
encountered, the TCR signal intensity, and the local
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cytokine milieu4,6–8. Indeed, Th1 differentiation, which is
required for host defense against intracellular pathogens,
involves interferon-γ (IFNγ) production in an interleukin
(IL)-2-dependent manner by the transcription factor T-
bet6. Th2 differentiation is triggered by extracellular
pathogens or allergens through the induction of GATA-3
and the activation of IL-4-dependent signal transducer
and activator of transcription factor 6 (Stat-6)9. Signals
emanating from the nuclear interior may also condition
naive T-cell polarization. Here we show that lamin A/C
expression augments CD4+ T-cell Th1 differentiation in
response to pathogen infection by regulating T-bet tran-
scription factor expression and IFNγ production.
Results
Lamin A/C regulates Th1 differentiation
To analyze the role of A-type lamins in antigen-
dependent T-cell differentiation, Lmna−/− and wild-type
(WT) mice were back-crossed with OTII mice, which
express a TCR (T-cell receptor) speciﬁc for ovalbumin
(OVA) peptide. Naive CD4+ T-cells were isolated from
Lmna−/−/OTII or WT/OTII mice and co-cultured with
OVA-loaded WT APCs in the absence of polarizing
cytokines. Compared with WT CD4+ T-cells, fewer
Lmna−/− CD4+ T-cells were IFNγ+, indicating the
importance of lamin A/C for antigen-dependent Th1
differentiation (Fig. 1a). This difference was not abolished
by addition of IL-2 (Fig. 1b). We next directed Th1 or Th2
differentiation in vitro by incubating WT and Lmna−/−
CD4+ T-cells with anti-CD3 and anti-CD28 antibodies
and Th1 or Th2 polarizing cytokines. Interestingly,
Lmna−/− CD4+ T-cells produced fewer Th1 cells than
WT cells but similar numbers of Th2 cells (Fig. 1c). Th1
differentiation triggered by co-culture with OVA-loaded
WT APCs in the presence of Th1 polarizing cytokines was
also lower in CD4+ T-cells from Lmna−/−/OTII mice
than in WT/OTII T-cells (Fig. 1d). These experiments
suggest that lamin A/C is an important intrinsic regulator
of T-cell differentiation following TCR stimulation.
Lamin A/C enhances Th1 responses in vivo
It has been previously shown that intrinsic lamin A/C
does not affect T-cell development10. Moreover, we did
not observe any role for lamin A/C in very early T-cell
activation. Indeed, TCR stimulation triggered similar levels
of extracellular signal–regulated kinase 1/2 (ERK1/2)
phosphorylation in WT and Lmna−/− CD4 T-cells (Fig-
ure S1a, day 0), indicating that lamin A/C is not involved
in T-cell development and early TCR activation. We have
previously shown that lamin A/C is transiently expressed
in CD4+ T-cells upon antigen recognition3. Conﬁrming
our previous observation, levels of pERK1/2 were
increased in WT lamin A/C-expressing cells but not in
Lmna−/− CD4 T-cells after a second TCR stimulation,
when lamin A/C is already expressed in WT CD4 T-cells
(ref. 3; and Figure S1b), (Figure S1a, day 1).
To investigate the role of lamin A/C in Th1 differ-
entiation in vivo, mice were infected with vaccinia virus
(VACV), which provokes a robust Th1 immune response
in mice11,12. VACV infection induces transient expression
of lamin A/C, peaking at 1 day after infection in draining
lymph nodes (Figure S2). At 3 days after intraperitoneal
VACV infection, the frequency of IFNγ+CD4+ T-cells in
mesenteric lymph nodes and peritoneal exudate was
lower in Lmna−/− mice than in WT mice (Fig. 2a, b). To
study the role of lamin A/C speciﬁcally in the immune
system, we reconstituted lethally irradiated WT CD45.1
mice with WT or Lmna−/− CD45.2 bone marrow for
2 months. Conﬁrmation of bone marrow reconstitution
with anti CD45.1 and CD45.2 antibodies revealed no
signiﬁcant differences between genotypes. After intra-
peritoneal infection with VACV, we analyzed the fre-
quency of IFNγ+ and IL-4+ in CD4+ T-cells. Lmna−/
−-reconstituted mice had proportionately fewer IFNγ+ T-
cells, and similar numbers of IL4+ T-cells with respect to
WT-reconstituted mice, in both spleen and peritoneal
exudate (Fig. 2c). To trigger antigen-speciﬁc Th1
responses in vivo, we reconstituted WT mice with either
WT/OTII or Lmna−/−/OTII bone marrow and then
infected the mice intraperitoneally with VACV-OVA. As
before, the Lmna−/−/OTII-reconstituted CD4+ popula-
tion included a lower proportion of IFNγ+ cells than did
WT/OTII-derived CD4+ cells (Fig. 2d). Moreover,
reconstitution with a mix of bone marrow fromWT/OTII
and Lmna−/−/OTII mice produced a lower percentage of
IFNγ+CD4+ T-cells in Lmna−/−/OTII than in WT/OTII
cells (Fig. 2e). Our results indicate that lamin A/C
depletion in the hematopoietic compartment impairs Th1
differentiation in vitro and in vivo. To directly assess the
importance for Th1 differentiation of lamin A/C in CD4+
T-cells, we adoptively transferred WT mice with CD4+ T-
cells from WT/OTII or Lmna−/−/OTII mice. Th1 dif-
ferentiation from Lmna−/− CD4+ T-cells was weaker
than from their WT counterparts, producing a lower
percentage of IFNγ+CD4+ T-cells (Fig. 3a). Similar results
were obtained when WT recipient mice were transferred
with a mix of WT/OTII and Lmna−/−/OTII CD4+ T-cells
followed by VACV-OVA inoculation, either intraper-
itoneally (Fig. 3b) or subcutaneously in the footpad
(Fig. 3c). These results indicate that lamin A/C expression
speciﬁcally regulates CD4+ T-cell differentiation toward
Th1 cells in vivo.
We next investigated whether the action of lamin A/C
in CD4+ T-cell polarization was related to antigen pre-
sentation by dendritic cells (DC). WT mice received
subcutaneous injections of lipopolysaccharide (LPS)-
matured OVA-loaded bone marrow-derived DCs
(BMDCs), which trigger Th1 differentiation13, and 18 h
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later received intravenous injections of WT/OTII or
Lmna−/−/OTII CD4+ T-cells. After 7 days, Th1 differ-
entiation of adoptively transferred T-cells was analyzed in
draining lymph nodes. Lmna−/−/OTII CD4+ T-cells
produced fewer IFNγ+CD4+ T-cells in the presence of
LPS-treated BMDCs than WT/OTII cells (Fig. 3d). In
other experiments, WT mice received subcutaneous
injections of splenic CD11c+ DCs incubated 4 h in med-
ium containing LPS or papain to potentiate antigen-
dependent T-cell differentiation to Th1 or Th2, res-
pectively13,14. As before, 18 h later the mice received
intravenous injections of WT/OTII or Lmna−/−/OTII
CD4+ T-cells, and Th1 and Th2 differentiation was ana-
lyzed in draining lymph nodes after 7 days. Lmna−/−
CD4+ T-cells produced fewer IFNγ+CD4+ T-cells in the
presence of LPS-treated BMDCs than their WT coun-
terparts; in contrast, in the presence of papain-treated
BMDCs the proportion of IL4+ cells was similar in WT
and Lmna−/− CD4+ T-cells (Fig. 3e). These results indi-
cate that lamin A/C expression speciﬁcally regulates
CD4+ T-cell differentiation toward Th1 cells in vivo.
Lamin A/C enhances T-cell activation but is not essential
for T-cell proliferation
Reduced Th1 cell polarization from Lmna−/− CD4+ T-
cells could be due to impaired T-cell activation, which is
enhanced by lamin A in vitro3. We therefore analyzed
CD4+ T-cell activation in response to VACV infection in
the absence of lamin A/C expression. A 1:1 mix of naive
CD4+ T-cells from Lmna−/−/OTII and WT/OTII mice
Fig. 1 Impaired in vitro Th1 differentiation of CD4+ T-cells from Lmna−/− mice. Percentage of IFNγ+ and IL4+ CD4+ T-cells isolated from WT or
Lmna−/− mice. a CD4+ T-cells from WT/OTII or Lmna−/−/OTII mice were cocultured with OVA-loaded WT APCs for 4 days. Data are means±SEM of at
least three independent experiments analyzed by unpaired Student’s t-test. b CD4+ T-cells were stimulated with anti-CD3/CD28 antibodies for 4 days
in the presence of IL-2. Data are means±SEM of at least ﬁve independent experiments analyzed by unpaired Student’s t-test. c CD4+ T-cells were
stimulated with anti-CD3/CD28 antibodies for 4 days in the presence of cytokines and antibodies to trigger Th1 or Th2 differentiation in vitro. Data
are means±SEM of at least four independent experiments analyzed by unpaired Student’s t-test. d CD4+ T-cells from WT/OTII or Lmna−/−/OTII mice
were cocultured with OVA-loaded WT APCs for 4 days in the presence of cytokines and antibodies to trigger Th1 differentiation. Data are means±SEM
of three independent experiments analyzed by unpaired Student’s t-test. **P < 0.01; ***P < 0.001
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was adoptively transferred into WT recipient mice before
intradermal infection with VACV-OVA. Surface expres-
sion of the T-cell activation markers CD25 and CD69 was
measured 48 h later (Fig. 4a, b). Accordingly, compared
with WT cells, Lmna−/− CD4+ T-cells in draining lymph
nodes expressed less CD25 and CD69.
Next, we investigated whether lamin A/C could regulate
T-cell proliferation, which occurs after antigen recogni-
tion and activation. However, proliferation after in vitro
activation with anti-CD3 and anti-CD28 was similar in
Lmna−/− and WT CD4+ T-cells (Fig. 4c). Similarly, after
VACV infection, WT and Lmna−/− mice had similar
levels of proliferating CD4+ T-cells, as shown by Ki67
expression (Fig. 4d), proliferating cell nuclear antigen
(PCNA) expression (Fig. 4e), and 5-bromo-2-
deoxyuridine (BrdU) incorporation (Fig. 4f–g). These
experiments show that A-type lamins regulate T-cell
activation without affecting cell proliferation.
Lamin A/C enhances T-bet levels
The master regulator of Th1 differentiation is T-bet.
Analysis of T-bet expression in CD4+ T-cells revealed
that deﬁciency in A-type lamins reduced both the per-
centage of T-bet+ cells and T-bet expression levels in
anti-CD3/CD28-stimulated CD4+ T-cells (Fig. 5a, b). In
agreement with the effect on Th1 differentiation, lamin A/
C deﬁciency also diminished the percentage of
IFNγ+CD4+ T-cells (Fig. 5a). Similar results were
obtained after stimulation with anti-CD3/CD28 anti-
bodies in the presence of Th1-differentiation cytokines
(Fig. 5c). Moreover, lamin A/C expression was also
important for T-bet expression in vivo after Th1 differ-
entiation triggered by VACV infection (Fig. 5d). Low T-
bet protein expression in Lmna−/− T-cells was accom-
panied by lower mRNA expression in vitro (Fig. 5e),
suggesting regulation at the level of mRNA synthesis.
A-type lamins regulate TCR clustering and subsequent
downstream signaling upon T-cell activation3. However,
altered Th1 differentiation in the absence of lamin A/C
was not exclusively related to differences in TCR clus-
tering, since the percentage of IFNγ+ and T-bet+ Lmna−/
− CD4+ T-cells was also lower after TCR-independent T-
cell stimulation with phorbol myristate acetate (PMA) and
ionomycin (Fig. 5a).
Lamin A/C regulates Th1 immunity against pathogen
infection
T-bet and IFNγ play major roles during in vivo Th1
responses against pathogens11,15,16. The low expression of
these factors in Lmna−/− CD4+ T-cells prompted us to
investigate the role of lamin A/C in Th1-mediated
pathogen clearance in vivo. Rag1−/−mice lacking T- and
B-cells were adoptively transferred with naive
CD25-CD4+ T-cells from WT or Lmna−/− mice. Mice
were infected with VACV by tail scariﬁcation. Without
CD4+ T-cell adoptive transfer, 100% of Rag1−/− mice die
12 days after VACV infection; CD4+ T-cell adoptive
transfer extends lifespan by accelerating viral clearance at
least in part through a mechanism mediated by
Th1 cells17. In our experiments, Rag1−/− mice adoptively
transferred with CD25-CD4+ Lmna−/− T-cells were more
susceptible to primary VACV infection, as indicated by an
elevated viral titer and a reduced Th1 response in the
spleen (Fig. 6a, b). Moreover, IFNγ and T-bet mRNA
expression was reduced in adoptively transferred mice,
whereas the Th2 transcription factor GATA3 was unaf-
fected (Fig. 6c). Viral clearance requires the efﬁcient
coordination of multiple immune effector mechanisms11.
The role of lamin A/C in viral clearance seems to be
CD4+ T-cell dependent, since only CD4+ T-cells were
adoptively transferred to Rag1−/− mice before VACV
infection. Effector CD4+ T-cells have been shown to
respond to viral pathogens through two mechanisms:
cytokine production (mostly IFNγ and tumor necrosis
factor-α (TNFα)) and a direct cytolytic activity mediated
by perforin and FAS (also known as CD95)11. CD4+ T-cell
cytotoxic activity does not require Th1 cell polarization
but is dependent on the expression of the transcription
factors T-bet, eomesodermin (Eomes), and Blimp-1,
which are crucial for their development in vivo through
the induction of granzyme B (GzmB) and perforin 1
(Prf1)18,19. Interestingly, Rag1−/− mice adoptively trans-
ferred with Lmna−/− CD4+ T-cells and scariﬁed with
VACV had lower levels of IFNγ mRNA in the large
(see ﬁgure on previous page)
Fig. 2 Impaired in vivo Th1 differentiation of naive CD4+ T-cells from Lmna−/− mice. Percentage of IFNγ+ or IL4+ CD4+ T-cells upon VACV
infection. a, bWT and Lmna−/−mice were intraperitoneally infected with VACV, and after 3 days mesenteric lymph nodes a and peritoneal exudate b
were analyzed, (n = 11 WT and 7 Lmna−/− mice). Data are means±SEM analyzed by unpaired Student’s t-test. c Irradiated CD45.1+ WT mice were
reconstituted with CD45.2+ WT or CD45.2+ Lmna−/− bone marrow and infected intraperitoneally with VACV. After 5 days, spleens and the peritoneal
exudate were analyzed by ﬂow cytometry (n = 7 and 8–11 mice from two independent experiments). Data are means±SEM analyzed by unpaired
Student’s t-test d Irradiated CD45.1+ WT mice were reconstituted with CD45.2+ WT/OTII or CD45.2+ Lmna−/−/OTII bone marrow and infected
intraperitoneally with VACV-OVA. After 5 days, peritoneal exudate was analyzed (n = 9 and 6 mice from 2 independent experiments). Data are means
±SEM analyzed by unpaired Student’s t-test. e Irradiated CD45.1+/CD45.2+ WT mice were reconstituted with a mix of CD45.1+ WT/OTII with CD45.2+
Lmna−/−/OTII bone marrow. Five days after VACV-OVA intradermal infection in the footpad, popliteal lymph nodes were analyzed (n = 9 and 9 mice
from 2 independent experiments). Data are means±SEM analyzed by paired Student’s t-test. *P < 0.05; **P < 0.01; ***P < 0.001
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intestine than mice receiving WT CD4+ T-cells (Fig. 6c).
In addition, we found that lamin A/C expression in CD4+
T-cells differentiated to Th1 in vitro positively regulates
the mRNA expression of eomes, Blimp1, GzmB, and Prf1
but not granzyme A (GzmA) (Figure S3). Lamin A/C also
regulates CD4+ T-cell cytoxicity in vivo, since VACV-
OVA-generated Lmna−/− Th1 cells were less efﬁcient to
kill OVA-loaded B220+MHCII+ B cells, after being
adoptively transferred to Rag1−/− mice (Figure S4).
We also analyzed the importance of lamin A/C
expression for Th1 responses against the intracellular
parasite L. major16. Mice on the C57BL/6 background
control L. major infection by developing a protective Th1
response20. C57BL/6 mice lacking lamin A/C in the whole
immune system (Fig. 6d–h) or speciﬁcally in T-cells
(Fig. 6i–k) developed progressively larger and non-healing
lesions (Fig. 6d, e, i) after inoculation of the ear dermis
with a low dose of L. major parasites. This effect corre-
lated with a higher parasite burden in the infection site
and in draining lymph nodes after 3 weeks (Fig. 6f, j). At
this time, Lmna−/− mice showed a reduced percentage of
IFNγ+ CD4+ T-cells (Fig. 6g, k), with less IFNγ produc-
tion (Fig. 6h). These results further support the role of
lamin A/C in Th1 responses against pathogens.
Discussion
The role of nuclear envelope proteins in the regulation
of immune homeostasis remains largely unknown21.
Similarly, little is known about the molecular signals that
switch immune function from protective to tissue dama-
ging. Adaptive immunity is ﬁnely regulated by the inter-
play between immune regulatory mechanisms and
effector T-cell responses. T-cells play central roles in
orchestrating the protection against diverse microbial
pathogens4. Many studies have investigated membrane
mediators important for T-cell fate decision, while others
have assessed the role of cytoplasmic proteins; however,
the importance of nuclear envelope proteins for naive T-
cell differentiation remained overlooked. Despite studies
characterizing signaling pathways from the membrane to
the nucleus, there is a lack of information about signals
arising in the nuclear interior and the role of nuclear
proteins in mediating the transmission of information to
the cytoplasm. It has been previously shown that intrinsic
lamin A/C deﬁciency does not affect T- and B-cell
development, driving the generation of functional and
self-MHC-restricted CD4+ and CD8+ T-cells10. We pre-
viously demonstrated that transient lamin A/C expression
in CD4+ T-cells after antigen recognition contributes to
T-cell activation3. In the present study, we have identiﬁed
the nuclear envelope protein lamin A/C as a crucial driver
of Th1 polarization, both in vitro and in vivo.
Lamin A/C is expressed upon T-cell activation, and its
deﬁciency downregulates the transcription factor T-bet,
thereby impairing naive CD4+ T-cell differentiation toward
the Th1 phenotype. Strikingly, this effect is not counter-
balanced by an increase in Th2 differentiation. Distinct
signaling pathways can drive T-cell differentiation22. In
response to TCR activation and mTOR costimulation, Akt
modulates transcription of T-bet but not Gata3, thus
affecting Th1 but not Th2 differentiation. In contrast, PKC-
θ activation yields the opposite result22. Lamin A/C is an
important regulator of gene transcription during adipose
tissue differentiation23 and controls the phosphorylation of
signaling molecules in other cellular contexts1,24. Indeed,
we previously showed that lamin A/C binds to ERK1/2 and
c-Fos, regulating AP-1 transcription factor target genes24,25
and that lamin A/C controls CD4+ T-cell activation
through ERK1/2 signaling3. Interestingly, the formation of
c-Fos/c-Jun dimers can potentiate Th1 differentiation26.
Lamin A/C thus seems to speciﬁcally regulate pathways
involved in Th1 differentiation, directly modulating the
transcription of Th1-related genes. This process occurs in a
TCR-dependent manner, although lamin A/C can also
regulate signaling downstream the TCR, as observed after
stimulation with PMA plus ionomycin.
The Th fate of antigen-engaged T-cells depends on
many factors, including the type of antigen encountered,
(see ﬁgure on previous page)
Fig. 3 Compromised in vivo Th1 differentiation of naive CD4+ T-cells from Lmna−/− mice. Percentage of IFNγ+ CD4+ T-cells. a Recipient
CD45.1+ WT mice were adoptively transferred with CD45.2+ WT/OTII or CD45.2+ Lmna−/−/OTII CD4+ T-cells. Five days after intraperitoneal VACV-OVA
infection, mesenteric lymph nodes and the peritoneal exudate were analyzed (n = 10 WT and 9 Lmna−/− mice from 2 independent experiments).
Data are means±SEM analyzed by unpaired Student’s t-test. b CD45.1+/CD45.2+ WT mice were adoptively transferred (AT) with a mix of CD45.1+ WT/
OTII and CD45.2+ Lmna−/−/OTII CD4+ T-cells and infected intraperitoneally with VACV-OVA. After 5 days, peritoneal exudate and mesenteric lymph
nodes were analyzed (n = 11 and 11 mice from 2 independent experiments) Data are means±SEM analyzed by paired Student’s t-test. c CD45.1+/
CD45.2+ WT mice were AT as in b, and after 5 days of intradermal infection with VACV-OVA the popliteal lymph nodes were analyzed (n = 6 and 6
mice from 2 independent experiments). Data are means±SEM analyzed by paired Student’s t-test d OVA-loaded LPS-matured BMDCs were AT to WT
recipient mice. After 18 h, recipients received intravenous injections of a mix of CD45.1+ WT and CD45.2+ Lmna−/−/OTII CD4+ naive T-cells. Four days
later, the popliteal lymph nodes were analyzed (n = 3 and 3 mice from 1 representative experiment out of 2). Data are means±SEM analyzed by
unpaired Student’s t-test e Isolated splenic CD11c+ cells were incubated with OVA and LPS or with OVA and papain for 4 h and then AT to WT
recipients. Control mice were transferred with CD11c+ cells in the absence of OVA (DC-OVA). After 18 h, recipients received intravenous injections of a
mix of CD45.1+ WT and CD45.2+ Lmna−/− CD4+ naive T-cells. Four days later, the popliteal lymph nodes were analyzed. The percentage of IL4+ CD4+
T-cells was also investigated (n = 4 and 4 mice from 2 independent experiments). Data are means±SEM analyzed by unpaired Student’s t-test. *P <
0.05; **P < 0.01; ***P < 0.001
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the TCR signal intensity, the duration of antigen pre-
sentation, and the local cytokine milieu4,6–8,26,27. Th1
differentiation is favored by stronger T-cell activation
signals and longer T–DC cell–cell interactions8,26. Lamin
A/C enhances T-cell activation by increasing TCR signal
strength and promoting T–DC interaction3. Weaker TCR
signal intensity in the absence of lamin A/C could account
for the observed reduction in CD4+ T-cell activation
triggered by VACV infection. However, this cannot fully
explain the differences in Th1 vs. Th2 differentiation in
lamin A/C-deﬁcient T-cells, indicating that additional
factors are involved. Regarding the cytokine milieu, IL-2,
IL-12, and IFNγ are known to facilitate Th1 differentia-
tion, whereas IL-4 favors Th2 differentiation. Moreover,
some cytokines promote differentiation to a speciﬁc Th
phenotype without affecting others. For example, IL-33
enhances Th1 but not Th2 polarization in the presence of
IL-1228. Lamin A/C expression could regulate the pro-
duction and release of cytokines important for Th1 phe-
notype. In this regard, we ﬁnd that lamin A/C deﬁciency
reduces membrane expression of the IL-2 receptor CD25
in CD4+ T-cells activated by VACV infection in vivo.
Incubation of CD4+ T-cells with IL-2 or Th1 polarizing
cytokines during in vitro differentiation did not rescue the
impaired Lmna−/− Th1 differentiation, indicating that
intracellular signals driven by the nuclear envelope pro-
tein lamin A/C directly regulate Th1 differentiation.
Viral clearance requires the efﬁcient coordination of
multiple immune effector mechanisms11. We show that
lamin A/C deﬁciency in CD4+ T-cells results in a defec-
tive Th1 differentiation, impairing the response against
VACV and delaying viral clearance. These results suggest
that lamin A/C is an essential component of the immune
response against cytopathic viruses. Remarkably, the role
of lamin A/C in viral clearance seems to be CD4+ T-cell
dependent, since only CD4+ T-cells were adoptively
transferred to T- and B-cell-deﬁcient Rag1−/− mice
before mouse infection with VACV. Accordingly, in
humans CD4+ T-cells are critical for antiviral immunity
and control of VACV replication12. CD4+ T-cells can also
regulate innate immune responses that mediate viral
clearance11, which is independent on B-cells and CD8+ T-
cells, and might be important for appropriate CD4+ T-cell
responses against VACV17. Interestingly, Lmna−/− CD4+
T-cells show reduced cytotoxic activity in vivo and
impaired in vitro mRNA expression of transcription fac-
tors involved in the regulation of CD4+ T-cell cytotoxi-
city, like eomes, Blimp1, GzmB, and Prf1.
The protozoan parasite L. major cause cutaneous
leishmaniasis29, usually provoking local self-healing skin
lesions in humans. However, the parasite can cause pro-
longed non-healing skin ulcers with extensive tissue
destruction and become systemically distributed29.
C57BL/6 mice develop protective immune responses
against L. major. We show that WT recipient C57BL/6
mice reconstituted with Lmna−/− bone marrow develop
poorer Th1 responses against this parasite, with worse
pathogen clearance than recipients of WT cells. The
immune response against L. major involves multiple cell
types. Importantly, our results clearly demonstrate that
lack of lamin A/C speciﬁcally in T-cells impaired healing
of ear lesions. C57BL/6 mice develop Th1-dependent
responses to L. major, and following a high L. major dose
the lesions heal in the absence of CD8+ T-cells30,31.
Moreover, cytolytic CD8+ T-cells are pathogenic when
recruited to Leishmania lesions in large numbers32.
Therefore, impaired responses observed in Lmnaﬂox/
ﬂox×CD4-CRE mice likely associate with lamin A/C-
deﬁcient CD4+ T-cells. The early immune response
determines whether L. major skin lesions will be self-
healing or chronic. C57BL/6 mice develop CD4+ Th1
cell-mediated resistance, whereas other mouse strains
develop CD4+ Th2 responses and are extremely suscep-
tible to infection33. Therefore, CD4+ Th1 cells are crucial
for reducing Leishmania infection34, producing IFNγ, IL-
2, and TNFα locally and leading to macrophage activation
and parasite elimination. Our experiments show a
diminished percentage of IFNγ-producing CD4+ T-cells
(see ﬁgure on previous page)
Fig. 4 Lmna−/− CD4+ T-cells show impaired in vivo and in vitro activation in response to VACV infection. a, bWT CD45.1+/CD45.2+ mice were
adoptively transferred with a mix of CD4+ T-cells from CD45.1+/OTII WT and CD45.2+/OTII Lmna−/− mice and then intradermally infected in the
footpad with VACV-OVA for 2 days. Spleen and popliteal lymph nodes were analyzed, and the expression of a CD25 and b CD69 was quantiﬁed (n =
6 mice). Data are means±SEM analyzed by unpaired Student’s t-test c Splenocytes from CD45.1+ WT/OTII and CD45.2+ Lmna−/−/OTII mice were
mixed, stained with cell violet, and cultured in the presence of OVA for 2 days. CD4+ T-cell proliferation was quantiﬁed and the number of cell
divisions is shown in the graph. Data are means±SEM of six independent experiments analyzed by two-way ANOVA with Bonferroni’s multiple
comparison test. d, e CD4+ T-cells from CD45.1+ WT and CD45.2+ Lmna−/− mice were mixed 1:1 and adoptively transferred to CD45.1/CD45.2 WT
mice. Recipient mice were then intraperitoneally infected with VACV for 7 days. The peritoneal exudates and mesenteric lymph nodes were analyzed,
and the percentage of d Ki67+ or e PCNA+ CD4+ T-cells was quantiﬁed (n = 5 mice from 2 independent experiments) Data are means±SEM analyzed
by unpaired Student’s t-test. f CD45.1+ WT recipient mice were transplanted with a 1:1 mix CD45.1+ WT and CD45.2+ Lmna−/− bone marrow and
infected intraperitoneally with VACV. Mice were injected with BrdU, and 24 h later the percentage of BrdU+ CD4+ T-cells was quantiﬁed in mesenteric
lymph nodes, peritoneal exudate, and spleen (n = 3 mice from 1 representative experiment) Data are means±SEM analyzed by paired Student’s t-test.
g CD4+ T-cells from CD45.2+ WT or CD45.2+ Lmna−/− mice were mixed 1:1 and adoptively transferred to CD45.1+/CD45.2+ WT mice. Recipient mice
were infected intraperitoneally with VACV for 6 days and injected with BrdU. After 24 h, the percentage of BrdU+ CD4+ T-cells was quantiﬁed in the
peritoneal exudate and mesenteric lymph nodes (n = 5 and 5 mice). Data are means±SEM analyzed by paired Student’s t-test. ***P < 0.001
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and reduced IFNγ production in Lmna−/− mice. IFNγ
secretion by CD4+ T-cells induces macrophages to pro-
duce nitric oxide and TNF, thus controlling L. major
infection33,35. This mechanism could explain the dimin-
ished pathogen clearance observed in the absence of
lamin A/C. Importantly, we show that lamin A/C in CD4+
Fig. 5 (See legend on next page.)
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T-cell is an important mediator of the immune control
against this pathogen.
Our study reveals a novel role for lamin A/C as a reg-
ulator of T-cell differentiation, controlling the main-
tenance of Th1 populations in response to pathogen
infections. These data contribute to the understanding of
the molecular mechanisms driving CD4+ T-cell responses
and suggest that strategies to modulate T-cell function
could provide a route toward therapeutic immunization
and long-lasting protection.
Materials and methods
Mice
Lmna−/− mice have been described previously36.
C57BL/6-Tg (TcraTcrb)425Cbn/J mice (OTII mice)
express a TCR speciﬁc for the OVA peptide (amino acid
residues 323–339) in the context of I-Ab and the CD4-
CRE and were obtained from the Jackson Laboratory
(stock number 004194 and 017336, respectively). C57BL/
6-CD45.2+Lmna−/− OTII mice were generated by
crossing C57BL/6-CD45.2+ OTII mice with C57BL/6-
CD45.2+Lmna−/− mice. C57BL/6-CD45.1+CD45.2+ WT
mice were generated by crossing C57BL/6-CD45.2+ mice
with C57BL/6-CD45.1+ mice. C57BL/6-CD45.1+ and
C57BL/6-CD45.1+CD45.2+ WT mice were used as reci-
pients for adoptive transfer. C57BL/6-CD45.1+CD45.2+/
OTII WT mice were generated by crossing C57BL/6-
CD45.2+/OTII mice with C57BL/6-CD45.1+/OTII mice.
Lmnaﬂox/ﬂox mice were kindly provided by Y. Zheng37.
C57BL/6Lmnaﬂox/ﬂoxCD4-CRE mice were generated by
crossing C57BL/6-CD4-CRE with C57BL/6-Lmnaﬂox/ﬂox
mice. C57BL/6 transgenic β-actin DsRed mice (Tg
(ACTB-DsRed*MST)1Nagy/J; The Jackson Laboratory)
was also used. All mice were bred at the CNIC in speciﬁc
pathogen-free conditions.
Animal experiments were approved by the local ethics
committee and the Spanish Ministry of Agriculture and
Fisheries, Food and Environment. All animal procedures
conformed to EU Directive 86/609/EEC and Recom-
mendation 2007/526/EC regarding the protection of ani-
mals used for experimental and other scientiﬁc purposes,
enforced in Spanish law under Real Decreto 1201/2005.
Antibodies and reagents
Anti-lamin-A/C (n-18), anti-p-ERK1/2, anti-PCNA, and
PE-conjugated anti-lamin A/C were obtained from Santa
Cruz Biotechnology. Alexa Fluor 488-conjugated anti-
lamin-A/C was obtained from Cell Signaling. Anti-CD3,
anti-CD28, ﬂuorescein isothiocyanate (FITC)-conjugated-
CD45.1, V450-conjugated anti-CD45.1, PerCPCy5.5-
conjugated anti-CD45.1, PerCPCy5.5-conjugated
anti-CD45.2, APC-conjugated anti-CD45.1, v450-
conjugated anti-CD45.2, FITC-conjugated anti-CD45.2,
APC-conjugated anti-IFNγ, and V450-conjugated anti-
CD4 were from Tonbo Bioscience. PECy5-conjugated
anti-CD45.1, PECy7-conjugated anti-CD45.1, PE-
conjugated anti-Tbet, FITC-conjugate anti-CD8, APC-
conjugated anti-CD69, APC-conjugated anti-CD25,
PE-conjugated anti-T-bet, FITC-conjugated anti-Ki67,
PE-conjugated anti-IL-4, and biotinylated antibodies
against B220, CD19, MHCII, CD11c, CD11b, CD44,
CD49b, IgM CD25, and CD8α were from BD Biosciences.
T-cell stimulation and polarization
CD4+CD25− T-cells from spleens were puriﬁed by
negative selection on separation columns (Miltenyi Biotec)
after labeling the cells with a cocktail of biotinylated anti-
bodies against B220, CD19, MHCII, CD11c, CD11b, CD44,
CD25, CD49b, IgM, and CD8α and a solution containing
streptavidin-bound magnetic microbeads (Miltenyi Biotec).
For polarizing experiments, CD4+CD25− T-cells from
WT/OTII and Lmna−/−/OTII mice were stimulated with
irradiated autologous WT APCs previously incubated with
OVA peptide (10 μg/ml) for 30min at 37 °C. CD4+CD25−
T-cells from WT and Lmna−/− mice were stimulated with
plate-bound anti-CD3 (10 μg/ml) and soluble anti-CD28
antibodies (2 μg/ml).
Polarizing conditions were as follows: for Th1 polar-
ization: IL-12 (10 ng/ml) and anti-IL-4 (4 μg/ml), with
only IL-2 (10 ng/ml) during the rest period; for Th2
polarization: IL-4 (10 ng/ml) and anti-IFNγ (4 μg/ml),
with only IL-2 (10 ng/ml) during the rest period. Anti-
bodies and cytokines were from BD bioscience and
Tonbo, respectively. Cells were cultured in RPMI-1640
medium (GIBCO) for the indicated times.
(see ﬁgure on previous page)
Fig. 5 Lmna−/− CD4+ T-cells show impaired in vitro and in vivo T-bet expression. a Percentage of IFNγ+ and T-bet+ cells after stimulation of
CD4+ T-cells from WT and Lmna−/− mice with anti-CD3/CD28 antibodies or PMA plus ionomycin for 4 days in the presence of IL-2 (Data are means
±SEM of at least 2 independent experiments analyzed by one-way ANOVA with Bonferroni’s multiple comparison test. b T-bet and lamin A/C
expression in WT and Lmna−/− CD4+ T-cells 48 h after stimulation with anti-CD3/CD28 antibodies (n = 12 and 12 mice). Data are means±SEM
analyzed by one-way ANOVA with Bonferroni’s multiple comparison test c Percentage of T-bet+ cells after stimulation of WT and Lmna−/− CD4+ T-
cells with anti-CD3/CD28 for 7 days in the presence of Th1 polarizing antibodies and cytokines (n = 5 and 6 mice from 2 independent experiments).
Data are means±SEM analyzed by unpaired Student’s t-test d Percentage of T-bet+ CD4+ T-cells in peritoneal exudates and mesenteric lymph nodes
of WT recipient mice reconstituted with a 1:1 mix of WT and Lmna−/− bone marrow and intraperitoneally infected with VACV for 6 days (n = 4 and 4
mice from 2 independent experiments). Data are means±SEM analyzed by paired Student’s t-test e RT-qPCR analysis of the indicated genes in WT
and Lmna−/− CD4+ T-cells stimulated in vitro with anti-CD3/CD28 antibodies (n = pools of 3 mice). Data are means±SEM from 3 independent
experiments analyzed by unpaired Student’s t-test *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001
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Adoptive transfer
Splenic CD4+CD25- T-cells from CD45.2+ Lmna−/−,
CD45.1+CD45.2+ WT, or CD45.2+ WT mice were iso-
lated by negative selection on MACS separation columns
(Miltenyi Biotec) after labeling the cells with a cocktail of
biotinylated antibodies against B220, CD19, MHCII,
CD11c, CD11b, CD44, CD25, CD49b, IgM, and CD8α, as
well as with a solution containing streptavidin-bound
magnetic microbeads (Miltenyi Biotec). Adoptive transfer
experiments were performed by inoculating CD45.1+ or
CD45.1+CD45.2+WT recipient mice with 1×106 isolated
CD4+ T-cells. In some experiments, CD45.1+CD45.2+
WT recipient mice were inoculated with a 1:1 mix of 2×
106 CD25−CD4+ T-cells obtained from the spleens of
Fig. 6 Lamin A/C deﬁciency enhances susceptibility to VACV and Leishmania major. a–c Rag1−/− mice were inoculated intravenously with
naive WT or Lmna−/− CD4+ T-cells and infected with VACV by tail scariﬁcation. After 10 days, animals were analyzed to determine a the percentage of
IFNγ+ CD4+ T-cells in the spleen (n = 7 and 5 mice), b the viral titers in the tail (n = 5 and 5 mice), and c the mRNA levels of T-bet (Tbx21), IFNγ, and
Gata3 in the gut (n = 7 and 8 mice). d–h WT mice were adoptively transferred with WT or Lmna−/− bone marrow. Two months after reconstitution,
Leishmania major promastigotes were injected intradermally in the ears (n = 8–9 mice). Lesion size d and ear thickness e were quantiﬁed at the
indicated times. f Parasite burden in ears and draining lymph nodes was measured 3 and 10 weeks after infection. g, h The percentages of g IFNγ+
CD4+ T-cells and h the CD4+ T-cell IFNγ content were quantiﬁed in the ears 3 weeks after infection. i–k WT and CD4-CRE Lmnaﬂox/ﬂox mice were
injected intradermally in the ears with Leishmania major promastigotes (n = 9 and 9 mice). i Lesion size at the indicated times. j Parasite burden in the
ears and draining lymph nodes at 3 weeks postinfection. k Percentage of IFNγ+ CD4+ T-cells in the ears. Data analysis in a–c, f–h, k: unpaired
Student’s t-test; d–e, i: two-way ANOVA with Bonferroni’s post-hoc multiple comparison test. *P < 0.05; **P < 0.01; ***P < 0.001
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CD45.2+ Lmna−/− and CD45.1+ WT mice. In VACV
experiments, adoptive cell transfer was performed 24 h
before inoculation with the VACV virus38. Similar adop-
tive transfers were performed with CD4+ T-cells isolated
from CD45.1+CD45.2+WT/OTII, CD45.1+WT/OTII, or
CD45.2+ Lmna−/− mice.
Generation of BMDCs
BMDCs were generated as described in ref. 39. BMDCs
were obtained from bone marrow cell suspensions after
culture on non-treated cell culture dishes in complete
RPMI 1640 medium supplemented with 10% fetal bovine
serum (FBS), 2 mM L-glutamine, 100mg/ml penicillin,
100mg/ml streptomycin, 50 mM 2-ME, and 20 ng/ml
GM-CSF (PeproTech, London, UK). Cells were collected
at day 9 and BMDCs were isolated as CD11c+ MHC-II+
Ly6G− cells. Maturation was induced after overnight
incubation with LPS from Escherichia coli O111:B4 (1 μg/
ml; Sigma-Aldrich).
Vaccinia virus, scariﬁcation assays, and viral titration in
organs
The VACV strain Western Reserve (WR, ATCC num-
ber VR-1354) was a gift from Jonathan W. Yewdell and
Jack R. Bennink (NIH, Bethesda, Maryland, USA). VACV
was propagated in BSC-40 cells and puriﬁed by sucrose
gradient ultracentrifugation. WT or OVA-expressing
VACV (1× 106 plaque-forming units) were adminis-
tered by intraperitoneal injection or intradermal injection
in the footpad38.
Animals were anesthetized with an intraperitoneal
injection of Ketamine (100 mg/kg body weight) and
Xylazine (10 mg/kg) diluted in sterile phosphate-buffered
saline (PBS). Thirty 1 cm scariﬁcations were made with a
26 G syringe along the base of the tail, avoiding bleed-
ing40. Then 10ml of PBS containing 107 VACV plaque-
forming units (p.f.u.) were added to the area and allowed
to air dry. For mock infection only, PBS was added.
Animals were euthanized and the tail aseptically
removed, weighed, frozen at −80 °C, and stored at −80 °C
until use. The samples were homogenized with a Tissue
Ruptor (QIAGEN, USA) in 0.5 ml Dulbecco’s modiﬁed
Eagle’s medium (DMEM) containing 100 U/ml penicillin
and 100 µg/ml streptomycin. The homogenates were
sonicated for 3 min at 40% amplitude, freeze-thawed twice
(−80 °C/37 °C), sonicated again under the same condi-
tions, and then serially diluted in DMEM without FBS. To
quantify p.f.u., the dilutions were added to monolayers of
CV-1 cells seeded on 24-well plates. The cells were pre-
incubated for 1 day at 37 °C and 5% CO2, the dilutions
(0.2 ml) were added to each well, and the cells were fur-
ther incubated under the same conditions for 1 h. After
this, 0.5 ml DMEM containing 0.5% FBS were added to
each well. After 24 h, the cells were stained for 5 min with
crystal violet solution (0.5% crystal violet, 10% ethanol,
and 1% paraformaldehyde) and washed again. Viral pla-
ques were counted and plaque number was multiplied by
the reciprocal of sample dilution and converted to p.f.u./
g.17
Leishmania parasites, preparation, inoculation, and
quantiﬁcation
In vivo experiments were carried out using L. major
Friedlin strain FV1 (MHOM/IL/80/Friedlin), generously
provided by Dr. D. Sacks (NIH)20. For Leishmania chal-
lenge, parasites were kept in a virulent state by passage in
mice. Parasites were cultured and differentiated as descri-
bed41. Mice were infected by i.d. injection of 103 or 5× 104
metacyclic L. major promastigotes into the dermis of both
ears. Lesion size in the ear was determined with digital
callipers (Duratool)20. The limiting dilution assay was used
to determine parasite number41. Parasite load was expres-
sed as the number of parasites in the whole organ.
Bone marrow transplantation
WT recipient mice received 13 Gy of total body irradia-
tion administered in two treatments from a 137Cs source.
Bone marrow cells from CD45.2+WT or CD45.2+ Lmna−/
− mice were transplanted into CD45.1+ WT recipients by
injection into the retro-orbital sinus immediately after
irradiation. A mix 1:1 of bone marrow cells from CD45.1+
WT and CD45.2+ Lmna−/− mice were transplanted into
CD45.1+CD45.2+ WT recipients by injection into the
retro-orbital sinus immediately after irradiation. Approxi-
mately 8 weeks after transplantation, the chimeric condi-
tion of the mice was assessed by ﬂow cytometric analysis of
blood cells stained with a combination of ﬂuorescently
labeled anti-CD45.1 and anti-CD45.2 antibodies to detect
T-cells from donor and from recipient mice, which con-
ﬁrmed that >90% of the cells analyzed were derived from
the transplanted bone marrow cells
Flow cytometry
CD4+ T-cells were stimulated with PMA (20 ng/ml)
(Sigma Aldrich) plus ionomycin (1 μg/ml) (Sigma Aldrich)
for 6 h. Brefeldin A (Sigma Aldrich) was added for the last
2 h to allow intracellular cytokine accumulation. Surface
antigens were stained with antibodies, then ﬁxed and
made permeable with either a Cytoﬁx/Cytoperm kit (BD
Pharmingen), then intracellular cytokines and transcrip-
tion factors in cells were stained. Data were acquired on
FACSCantoII or LSRFortessa ﬂow cytometers (BD Bios-
ciences) and analyzed with the BD FACSDIVA (BD
Biosciences) or FlowJo (Treestar Inc) software.
Reverse transcription–quantitative PCR
Total RNA was isolated with Qiazol Lysis Reagent
(Qiagen) and isopropanol precipitation or with the
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RNeasy Mini kit (Qiagen), according to the manu-
facturer’s instructions. RNA concentration and purity
were assessed from the ratio of absorbances at 260 and
280 nm. Complementary DNA (cDNA) was synthesized
from total RNA (0.1–1 µg per reaction) with the High
Capacity cDNA Reverse Transcription Kit (Applied Bio-
systems) using random primers and RNase Inhibitor,
according to the manufacturer’s protocol. Quantitative
PCR was performed with the ABI PRISM 7900HT
Sequence Detection System (Applied Biosystems) using
the PCR Power SYBR Green PCR Master Mix (Applied
Biosystems), with technical triplicates.
The sequences of RT-qPCR primers were as follows:
T-Bet-Forward 5′-GAAAGGCAGAAGGCAGCAT-3′;
T-Bet-Reverse 5′-GAGCTTTAGCTTCCCAAATGAA-3′;
Hprt1-Forward 5′-CCTAAGATGAGCGCAAGTTGAA-
3′ and Hprt1-Reverse 5′-CCACAGGACTAGAACACCT
GCTAA-3′; GzmA-Forward 5′-GACTGCTGCCCACTG-
TAACG-3′; GzmA-Reverse 5′-TCAATATCTGTTGT
TCTGGCTCCTTA-3′; GzmB-Forward 5′-TGTCTCTGG
CCTCCAGGACAA-3′; GzmB-Reverse 5′- CTCAGGC
TGCTGATCCTTGATCGA-3′; Prf1-Forward 5′- GCGT
CTCCAGTGAATACAAAG-3′; Prf1-Reverse 5′- TACTT
CGACGTGACGCT-3′; Eomes-Forward 5′-GCCTAC-
CAAAACACGGATA-3′; Eomes-Reverse 5′-TCTGTT
GGGGTGAGAGGAG-3′; Ifng-Forward 5′- TGGCTCT
GCAGGATTTTCATG-3′; Ifng-Reverse 5′- TCAAGTGG
CATAGATGTGGAAGAA-3′; Blimp-1-Forward 5′-
ACACACAGGAGAGAAGCCACATGA-3′; Blimp-1-
Reverse 5′- TCGAAGGTGGGTCTTGAGATTGCT-3′;
gapdh-Forward 5′-CTACACTGAGGACCAGGTTGTC-
3′; gapdh-Reverse 5′-GGTCTGGGATGGAAATTGTG-
3′. Lmnb1-Forward 5′-CAACTGACCTCATCTGGAA-
GAAC 3′; Lmnb1-Reverse 5′-TAAGACTGTGCTTC
TCTGAGC-3′; Lmna-Forward-5′-TGAGTACAACCTG
CGCTCAC-3′; and Lmna-Reverse: 5′-TGACTAGG
TTGTCCCCGAAG-3′. The extent of expression of a gene
of interest was analyzed by the comparative Ct method
with the Biogazelle qBasePLUS software using as internal
control the housekeeping genes GAPDH (glyceraldehyde-
3-phosphate dehydrogenase) and HPRT1 (hypoxanthine
phosphoribosyltransferase 1). Results are represented as
fold change relative to control conditions.
Proliferation assays
Twenty-four hours before the sacriﬁce of the mice, a
single dose of 1 mg BrdU (BD Pharmingen) was injected
intraperitoneally (i.p.). To assess BrdU incorporation,
mesenteric lymph nodes, peritoneal exudate, and spleen
were stained for CD4, ﬁxed, and permeabilized using the
BD BrdU Flow Kit (BD Pharmigen) according to the
manufacturer’s instructions. Cells were incubated at 37 °C
for 60 min in 30 µg of DNase, followed by staining with
anti-BrdU-FITC for 40min, washed, and analyzed by ﬂow
cytometry. Peritoneal exudate and mesenteric lymph node
cells were ﬁxed and permeabilized using Foxp3 ﬁxation/
permeabilization buffer (BD Pharmingen) and stained for
PCNA-FITC and Ki67-FITC.
In vivo cytotoxicity assays
Splenic CD45.2+WT or CD45.2+Lmna−/− CD4+/OTII
T-cells were isolated as described in the adoptive transfer
section. Recipient Rag1−/− mice were inoculated intra-
venously with 2× 106 of either naive CD45.2/WT or
CD45.2/Lmna−/− CD4+/OTII T-cells and infected with
VACV-OVA i.p. After 5 days, splenocytes from CD45.2/
WT/dsRED and CD45.1/WT mice were isolated and
loaded or not with OVA OTII peptide, respectively. An
approximately 1:1 mix of 5× 106 CD45.2/WT/dsRED and
CD45.1/WT splenocytes was inoculated intravenously in
the recipient Rag1−/− mice, which were previously
inoculated and vaccinia infected. After 16 h, animals were
analyzed to determine the killing capacity of CD4/OTII
cells in the spleen by ﬂow cytometry. Killing capacity was
determined as the ratio between CD45.2/WT/dsRED/
+OVA and CD45.1/WT/-OVA cells and the percentage
of CD4/OTII T-cells. Mice adoptively transferred with
CD4/OTII cells only and mice transferred with spleno-
cytes in the absence of CD4/OTII cells were used as
controls.
Statistical analysis
Statistical analyses were performed with Prism Graph-
Pad or Microsoft Ofﬁce Excel. Unless otherwise stated,
statistical signiﬁcance was calculated by two-tailed Stu-
dent’s t-test. When speciﬁed, one-way analysis of variance
(ANOVA) or two-way ANOVA with Bonferroni’s post-
hoc multiple comparison test was used. Signiﬁcance of
differences was calculated as follows: *P< 0.05, **P< 0.01,
***P< 0.001, and **** P> 0.0001.
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